Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes.
about
Neuroprotection as a Therapeutic Target for Diabetic RetinopathyInsights into Substrate Specificity and Metal Activation of Mammalian Tetrahedral Aspartyl AminopeptidaseThe hypoglycemic effect of the kelp on diabetes mellitus model induced by alloxan in ratsNeurodegeneration: An early event of diabetic retinopathy.Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives.The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy.Immunochemical detection of oxidatively damaged DNA.Current knowledge on diabetic retinopathy from human donor tissues.Edaravone protect against retinal damage in streptozotocin-induced diabetic mice.Accumulation of exogenous amyloid-beta peptide in hippocampal mitochondria causes their dysfunction: a protective role for melatonin.Time for new guidelines in advanced diabetes care: Paradigm change from delayed interventional approach to predictive, preventive & personalized medicine.Angiotensin receptor blockade recovers hepatic UCP2 expression and aconitase and SDH activities and ameliorates hepatic oxidative damage in insulin resistant rats.Non-traditional systemic treatments for diabetic retinopathy: an evidence-based reviewPoly (ADP-ribose) polymerase mediates diabetes-induced retinal neuropathy.Advances in the medical treatment of diabetic retinopathy.Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress.Diabetic microvascular complications: possible targets for improved macrovascular outcomesMacular structure and function and the development of retinopathy in diabetes.Neuroprotection in diabetic retinopathy.Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications.Neurodegeneration as a primary change and role of neuroprotection in diabetic retinopathy.Combating Combination of Hypertension and Diabetes in Different Rat ModelsRole of Tissue Renin-angiotensin System and the Chymase/angiotensin-(1-12) axis in the Pathogenesis of Diabetic Retinopathy.Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes.Renin-Angiotensin system hyperactivation can induce inflammation and retinal neural dysfunction.Diabetes exacerbates retinal oxidative stress, inflammation, and microvascular degeneration in spontaneously hypertensive rats.Neurodegeneration in diabetic retina and its potential drug targets.Reduction of inducible nitric oxide synthase via angiotensin receptor blocker prevents the oxidative retinal damage in diabetic hypertensive rats.Erythropoietin (EPO) protects against high glucose-induced apoptosis in retinal ganglional cells.Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy.Effects of the neuroprotective drugs somatostatin and brimonidine on retinal cell models of diabetic retinopathy.Neuroprotective Effects of Rutin in Streptozotocin-Induced Diabetic Rat Retina.Iron Overload Accelerates the Progression of Diabetic Retinopathy in Association with Increased Retinal Renin Expression.Zucker diabetic fatty rats, a model for type 2 diabetes, develop an inner ear dysfunction that can be attenuated by losartan treatment.Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats.Microangiopathy and visual deficits characterize the retinopathy of a spontaneously hypertensive rat model with type 2 diabetes and metabolic syndrome.Magnetic resonance imaging retinal oximetry: a quantitative physiological biomarker for early diabetic retinopathy?Intraretinal changes in idiopathic versus diabetic epiretinal membranes after macular peeling.
P2860
Q26749178-315E65E4-3B2E-4B34-980F-940794742DACQ27677420-47A6F849-6F33-4B9F-93E8-F80B9256A15CQ28730796-EEC318CE-114C-4406-BDF1-3A1CE16FC0EAQ33887925-6A212AEA-ACC4-4686-A8EC-61C1E86523CFQ34081808-E330DF9E-20D4-42CA-8ED5-298A6C1E74F3Q34100527-6BF040B2-BF15-4F50-9E6C-240D044BFC74Q34228272-A7D0B595-D24A-4E8D-84B9-90DB1430CD56Q35179240-321861F9-EC5B-43D2-A37C-43A964232C43Q35181567-3BCE4DE2-96C4-4C5B-A385-010F1A520528Q35986729-F017DDD7-EFAC-4527-9547-59F885919BD0Q36117556-54F48900-40AC-4FC8-99BF-6467A1B34C24Q36439575-67E3FE34-5CC4-4400-A9C7-FECA5E05F07BQ37204025-702EBDD6-E30D-4124-80F2-14068BF907A5Q37379837-A722F6D8-DB47-4FA8-8599-A361E7DDF5FFQ37564793-06C0DF7B-FC5B-4AF9-BD12-05D94FA1C444Q37785713-540C1C01-3A01-4D8A-8D8B-00D3CA832FFDQ37828061-A560E774-8397-4816-9E9A-2399B8CE7AB8Q37892915-F45C45D7-082D-421B-AB09-17E40AB54DE5Q37950419-4E9CEC31-DD42-4F66-BC62-729DF2740F33Q38009713-3F1B3CEA-FA35-4150-80F2-6FCD1C00FD50Q38112711-CF338013-5534-4281-AC27-F6511C27F485Q38211670-5C206B1E-17F7-46C3-9FC1-DDE53A808740Q38974232-3A0B1888-798F-4A46-B76F-E9B4F487C9A1Q39238324-A7BA933F-ACB4-4C9A-AA6F-E821B618B8D3Q42084102-0F4B9180-49AD-4AEA-BF08-9A3319BD2F56Q42098043-9F836C1B-81B6-4FD1-8F6A-81ADC92F3388Q42210819-70ABAE95-A81B-4BB4-A80E-85961509BFE2Q42957709-570AA6A0-91D0-4E68-89DE-5C888A58F4EAQ43064763-C8EC2DA6-8E6A-4B21-AFE5-B4F275E50ADFQ46829128-FC7DE2F9-DA75-4810-8140-EEB5ABB19BD6Q47117481-30CB532B-B1AA-41E0-9E1E-E65F3000F46FQ48099809-0138503E-B996-40A7-A6D7-0BE2F1F1A135Q48199896-BCF6E826-F4B0-4ECD-84F2-856E8FD0B576Q50333811-98A3F882-87DF-488F-887C-C6D82DF5B37EQ50352478-2F2792FF-D567-4284-AA74-92158EBD0B1DQ51034962-C3A56402-F6CB-491E-B91F-387630455116Q52901126-BDD36DDF-9597-47B8-B536-7A6A7B78D2E1Q53202921-549B143B-1703-48C2-81F3-1CF0B2FA66B7Q54941317-C2DAFDFF-9D67-40DB-95AA-EA3EFB2AAF70
P2860
Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diabetic retinal neurodegenera ...... ing hypertension and diabetes.
@en
Diabetic retinal neurodegenera ...... ing hypertension and diabetes.
@nl
type
label
Diabetic retinal neurodegenera ...... ing hypertension and diabetes.
@en
Diabetic retinal neurodegenera ...... ing hypertension and diabetes.
@nl
prefLabel
Diabetic retinal neurodegenera ...... ing hypertension and diabetes.
@en
Diabetic retinal neurodegenera ...... ing hypertension and diabetes.
@nl
P2093
P2860
P356
P1433
P1476
Diabetic retinal neurodegenera ...... ing hypertension and diabetes.
@en
P2093
Jacqueline M Lopes de Faria
Jose B Lopes de Faria
Kamila C Silva
Mariana A B Rosales
P2860
P304
P356
10.2337/DB09-0166
P407
P577
2009-03-16T00:00:00Z